Target is trying to become the premier destination for new parents with a bunch of new products.
Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results